Cell viability and colony-formation assays are conducted to evaluate the anti-proliferative effects of degraders to NSCLC cell lines, and apoptosis assays are assessed by Annexin V‐FITC/PI dual staining followed by flow cytometry. This evidence concerns the gene ANXA5 and non-small cell lung carcinoma.